Marinova, M.*, Mücke, M.*, Mahlberg, L., Essler, L., Cuhls, H., Radbruch, L., Conrad, R.*, Ahmadzadehfar., H.* (*authors contributed equally) Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30. In press European Journal of Nuclear medicine and Molecular Imaging. 2017
Yordanova A, Ahmadzadehfar H, Gonzalez-Carmona M, Strassburg C, Mayer K, Feldmann G, Schmidt-Wolf I, Lingohr P, Fischer S, Kristiansen G, Essler M.A
Step-by-Step Clinical Approach for the Management of Neuroendocrine Tumours. Horm Metab Res. 2017 Feb;49(2):77-85.
Yordanova A, Mayer K, Brossart P, Gonzalez-Carmona MA, Strassburg CP, Essler M, Ahmadzadehfar H.
Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour. Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1207-1214
Yordanova A, Mayer K, Essler M, Ahmadzadehfar H.
Successful Repeated Peptide Receptor Radionuclide Therapies in Renal Neuroendocrine Tumor With Osseous Metastasis. Clin Nucl Med. 2016 Dec;41(12):977-979.
Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M.
Theranostics in nuclear medicine practice. Onco Targets Ther. 2017 Oct 3;10:4821-4828.